ATE312599T1 - Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten - Google Patents

Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten

Info

Publication number
ATE312599T1
ATE312599T1 AT00964471T AT00964471T ATE312599T1 AT E312599 T1 ATE312599 T1 AT E312599T1 AT 00964471 T AT00964471 T AT 00964471T AT 00964471 T AT00964471 T AT 00964471T AT E312599 T1 ATE312599 T1 AT E312599T1
Authority
AT
Austria
Prior art keywords
liposomes
vaccines
nucleic acid
oral use
contain liposomes
Prior art date
Application number
AT00964471T
Other languages
German (de)
English (en)
Inventor
Gregory Gregoriadis
Yvonne Perrie
Original Assignee
Lipoxen Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipoxen Technologies Ltd filed Critical Lipoxen Technologies Ltd
Application granted granted Critical
Publication of ATE312599T1 publication Critical patent/ATE312599T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00964471T 1999-10-01 2000-10-02 Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten ATE312599T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99307786 1999-10-01
PCT/GB2000/003773 WO2001024773A1 (en) 1999-10-01 2000-10-02 Liposome-entrapped dna oral vaccines

Publications (1)

Publication Number Publication Date
ATE312599T1 true ATE312599T1 (de) 2005-12-15

Family

ID=8241653

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00964471T ATE312599T1 (de) 1999-10-01 2000-10-02 Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten

Country Status (11)

Country Link
US (1) US7008791B1 (cg-RX-API-DMAC7.html)
EP (1) EP1217989B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003529550A (cg-RX-API-DMAC7.html)
KR (1) KR100744237B1 (cg-RX-API-DMAC7.html)
CN (1) CN1196474C (cg-RX-API-DMAC7.html)
AT (1) ATE312599T1 (cg-RX-API-DMAC7.html)
AU (1) AU7540500A (cg-RX-API-DMAC7.html)
CA (1) CA2386024A1 (cg-RX-API-DMAC7.html)
DE (1) DE60024843T2 (cg-RX-API-DMAC7.html)
ES (1) ES2256043T3 (cg-RX-API-DMAC7.html)
WO (1) WO2001024773A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4294584B2 (ja) 2002-07-05 2009-07-15 リポクセン・テクノロジーズ・リミテツド 核酸ワクチン接種の免疫応答を高めるための方法
WO2004100928A1 (de) * 2003-05-09 2004-11-25 Novosom Ag Injizierbare liposomale depots zum wirkstoffdelivery
JP4255396B2 (ja) * 2004-03-19 2009-04-15 津田駒工業株式会社 水噴射式織機の水受け装置
CA2687208C (en) * 2006-12-22 2017-02-14 Soluciones Biotecnologicas Innovacion Ltda Process and formulation for immunizing fish in aquaculture systems
AU2008227852B2 (en) * 2007-03-19 2011-02-24 Fresenius Kabi Oncology Ltd. Proliposomal and liposomal compositions
CN101940321B (zh) * 2010-08-06 2012-06-20 南昌大学 动态高压微射流-冻融法制备中链脂肪酸纳米脂质体
CN101940320B (zh) * 2010-08-06 2012-08-29 南昌大学 薄膜分散-动态高压微射流制备中链脂肪酸纳米脂质体
EP2708134A1 (en) 2012-09-17 2014-03-19 Unilever N.V. Dough compositions comprising a structured fat phase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0938298B1 (en) 1996-09-13 2002-12-04 Lipoxen Technologies Limited Liposome-based composition
FR2760193B1 (fr) * 1997-02-28 1999-05-28 Transgene Sa Lipides et complexes de lipides cationiques et de substances actives, notamment pour la transfection de cellules

Also Published As

Publication number Publication date
CN1196474C (zh) 2005-04-13
DE60024843D1 (de) 2006-01-19
ES2256043T3 (es) 2006-07-16
CN1376056A (zh) 2002-10-23
JP2003529550A (ja) 2003-10-07
WO2001024773B1 (en) 2001-08-16
US7008791B1 (en) 2006-03-07
KR20030011763A (ko) 2003-02-11
KR100744237B1 (ko) 2007-07-30
DE60024843T2 (de) 2006-08-10
EP1217989B1 (en) 2005-12-14
CA2386024A1 (en) 2001-04-12
AU7540500A (en) 2001-05-10
EP1217989A1 (en) 2002-07-03
WO2001024773A1 (en) 2001-04-12

Similar Documents

Publication Publication Date Title
US11850294B2 (en) Buffered microencapsulated compositions and methods
US5651959A (en) Ultramulsion based oral care compositions
CA2241247A1 (en) Archaeosomes, archaeosomes containing coenzyme q10, and other types of liposomes containing coenzyme q10 as adjuvants and as delivery vehicles
WO2003030934A3 (en) Cpg formulations and related methods
WO2002041765A3 (en) Biodegradable bioadhesive controlled release system of nano-particles for oral care products
ATE186212T1 (de) Geschmacksmaskierte pharmazeutische mittel
TW200507874A (en) Immunostimulatory nucleic acid oil-in-water formulations and related methods of use
ATE198040T1 (de) Feste fettnanoemulsionen als wirkstoffabgabevehikel
ATE355826T1 (de) Verfahren zur verkapselung von nukleinsäuren in lipiddoppelschichten
JO3404B1 (ar) تركيبة صيدلانية سائلة تحتوي على مشتقات اريثروبويتين
ATE234919T1 (de) Antisense nukleinsäuren zur vorbeugung und behandlung von beschwerden in welchen die exprimierung von c-erbb-2 eine rolle spielt
ATE326205T1 (de) Tensidfreietopische zusammensetzungen und verfahren zur schnelle herstellung davon
AU2001295671A1 (en) Pharmaceutical composition for immunisation against aids
BRPI0418228A (pt) forma de dosagem, e, métodos de tratamento de dor e de episódios de dor incidente de cáncer, e de preparação de um tablete para administração bucal, gengival ou sublingual de fentanil
DE60024843D1 (de) Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten
ATE285239T1 (de) Dna enthaltende impfstoffen
US5733529A (en) Ultramulsion based antigingivitis toothpaste compositions
MXPA05013270A (es) Forma de administracion transmucosal con irritacion mucosal reducida. reducida.
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
WO2003050067A3 (fr) Analogues de la vitamine d
BR9807927A (pt) Uso de uma leishmania mutante na preparação de uma vacina, formulação de vacina, processo de vacinação contra leishmania, uso de uma leishmania mutante na preparacão de uma vacina para a profilaxia e/ou o tratamento de leishmaniose, e, formulação farmacêutica
WO2001082892A3 (de) Wirkstoffhaltige liposome
DE60124862T2 (de) Verbesserte dns-impfstoffe für rinder-herpes-virus 1
ATE121298T1 (de) Verfahren zur herstellung eines antikaries- impfstoffes aus streptococcus mutans und impfzusammensetzung gegen karies in form von nasentropfen.
JP2003529550A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties